WuXi Biologics (Cayman) Inc logo

WuXi Biologics (Cayman) Inc

WXIBF · OTC · Pharmaceuticals, Biotech · Founded 2014

Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. It operates through the Biologics and XDC segments.

Current Price
—
Market Cap
—
Return Since Last Split
-46%
Last Split
Dec 10, 2020
Total Splits
1
Cumulative Multiple
3×

What If You Bought WXIBF Earlier?

Investment
Purchase Date (Before Split)
Worth Today
—
300 shares · 3×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
Dec 10, 2020$3.433-for-13×3×

WuXi Biologics (Cayman) Inc Market Cap Timeline

A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Validated annual history unavailable

At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.

Recorded split dates

Frequently Asked Questions

WuXi Biologics (Cayman) Inc's latest record in the split calendar is a 3-for-1 forward split effective 2020-12-10.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.